Alpha Tau Medical (DRTS) Operating Leases (2022 - 2026)

Alpha Tau Medical has reported Operating Leases for 5 years, with the latest figure at $6.7 million in Q1 2026.

• Quarterly Operating Leases rose 15.76% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 15.76% YoY) and the FY2025 annual result came in at $6.2 million, up 4.68% from the prior year.
• Operating Leases grew to $6.7 million in Q1 2026 per DRTS's latest filing, from $6.2 million in the prior quarter.
• Over five years, Operating Leases peaked at $6.7 million in Q1 2026 and troughed at $4.5 million in Q4 2022.
• A 5-year average of $5.9 million and a median of $6.1 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2024: Operating Leases soared 45.98% in 2023, then fell 9.69% in 2024.
• Over 5 years, Operating Leases stood at $4.5 million in 2022, then surged by 45.98% to $6.6 million in 2023, then dropped by 9.69% to $6.0 million in 2024, then increased by 4.68% to $6.2 million in 2025, then gained by 7.91% to $6.7 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $6.7 million, $6.2 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.